This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kido, Y. Articles by Accili, D. Search for Related Content PubMed PubMed Citation Articles by Kido, Y. Articles by Accili, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

The Insulin Receptor and Its Cellular Targets¹

Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New York 10032

Address all correspondence and requests for reprints to: Domenico Accili, M.D., Russ Berrie Science Pavilion, 1150 St. Nicholas Avenue, New York, New York 10032. E-mail: da230{at}columbia.edu

The pleiotropic actions of insulin are mediated by a single receptor tyrosine kinase. Structure/function relationships of the insulin receptor have been conclusively established, and the early steps of insulin signaling are known in some detail. A generally accepted paradigm is that insulin receptors, acting through insulin receptor substrates, stimulate the lipid kinase activity of phosphatidylinositol 3-kinase. The rapid rise in Tris-phosphorylated inositol (PIP₃) that ensues triggers a cascade of PIP₃-dependent serine/threonine kinases. Among the latter, Akt (a product of the akt protooncogene) and atypical protein kinase C isoforms are thought to be involved in insulin regulation of glucose transport and oxidation; glycogen, lipid, and protein synthesis; and modulation of gene expression. The presence of multiple insulin-regulated, PIP₃-dependent kinases is consistent with the possibility that different pathways are required to regulate different biological actions of insulin. Additional work remains to be performed to understand the distal components of insulin signaling. Moreover, there exists substantial evidence for insulin receptor substrate- and/or phosphatidylinositol 3-kinase-independent pathways of insulin action. The ultimate goal of these investigations is to provide clues to the pathogenesis and treatment of the insulin resistant state that is characteristic of type 2 diabetes.

This article has been cited by other articles:

				J. Zdychova, L. Kazdova, T. Pelikanova, J. N. Lindsley, S. Anderson, and R. Komers Renal Activity of Akt Kinase in Obese Zucker Rats Experimental Biology and Medicine, October 1, 2008; 233(10): 1231 - 1241. [Abstract] [Full Text] [PDF]

				R. MacLaren, W. Cui, S. Simard, and K. Cianflone Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue J. Lipid Res., February 1, 2008; 49(2): 308 - 323. [Abstract] [Full Text] [PDF]

				F. Frasca, G. Pandini, R. Malaguarnera, A. Mandarino, R. L. Messina, L. Sciacca, A. Belfiore, and R. Vigneri Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling J. Biol. Chem., September 7, 2007; 282(36): 26077 - 26088. [Abstract] [Full Text] [PDF]

				H. Miyamoto, K. Moriishi, K. Moriya, S. Murata, K. Tanaka, T. Suzuki, T. Miyamura, K. Koike, and Y. Matsuura Involvement of the PA28{gamma}-Dependent Pathway in Insulin Resistance Induced by Hepatitis C Virus Core Protein J. Virol., February 15, 2007; 81(4): 1727 - 1735. [Abstract] [Full Text] [PDF]

				H.-J. He, T.-N. Zhu, Y. Xie, J. Fan, S. Kole, S. Saxena, and M. Bernier Pyrrolidine Dithiocarbamate Inhibits Interleukin-6 Signaling through Impaired STAT3 Activation and Association with Transcriptional Coactivators in Hepatocytes J. Biol. Chem., October 20, 2006; 281(42): 31369 - 31379. [Abstract] [Full Text] [PDF]

				I.A.A. Penna, P.R.B. Canella, R.M. Reis, M.F. Silva de Sa, and R.A. Ferriani Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study Hum. Reprod., September 1, 2005; 20(9): 2396 - 2401. [Abstract] [Full Text] [PDF]

				B. C. Villafuerte and E. N. Kaytor An Insulin-response Element-binding Protein That Ameliorates Hyperglycemia in Diabetes J. Biol. Chem., May 20, 2005; 280(20): 20010 - 20020. [Abstract] [Full Text] [PDF]

				H. Sugita, M. Fujimoto, T. Yasukawa, N. Shimizu, M. Sugita, S. Yasuhara, J. A. J. Martyn, and M. Kaneki Inducible Nitric-oxide Synthase and NO Donor Induce Insulin Receptor Substrate-1 Degradation in Skeletal Muscle Cells J. Biol. Chem., April 8, 2005; 280(14): 14203 - 14211. [Abstract] [Full Text] [PDF]

				B. J. Goldstein, K. Mahadev, and X. Wu Redox Paradox: Insulin Action Is Facilitated by Insulin-Stimulated Reactive Oxygen Species With Multiple Potential Signaling Targets Diabetes, February 1, 2005; 54(2): 311 - 321. [Abstract] [Full Text] [PDF]

				P. Voisine, M. Ruel, T. A. Khan, C. Bianchi, S.-H. Xu, I. Kohane, T. A. Libermann, H. Otu, A. R. Saltiel, and F. W. Sellke Differences in Gene Expression Profiles of Diabetic and Nondiabetic Patients Undergoing Cardiopulmonary Bypass and Cardioplegic Arrest Circulation, September 14, 2004; 110(11_suppl_1): II-280 - II-286. [Abstract] [Full Text] [PDF]

				D Basso, C Millino, E Greco, C Romualdi, P Fogar, A Valerio, M Bellin, C-F Zambon, F Navaglia, N Dussini, et al. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes Gut, August 1, 2004; 53(8): 1159 - 1166. [Abstract] [Full Text] [PDF]

				A. R. Gosmanov, G. E. Umpierrez, A. H. Karabell, R. Cuervo, and D. B. Thomason Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E8 - E15. [Abstract] [Full Text] [PDF]

				M. Ohsugi, C. Cras-Meneur, Y. Zhou, W. Warren, E. Bernal-Mizrachi, and M. A. Permutt Glucose and Insulin Treatment of Insulinoma Cells Results in Transcriptional Regulation of a Common Set of Genes Diabetes, June 1, 2004; 53(6): 1496 - 1508. [Abstract] [Full Text] [PDF]

				A. D. Krisan, D. E. Collins, A. M. Crain, C. C. Kwong, M. K. Singh, J. R. Bernard, and B. B. Yaspelkis III Resistance training enhances components of the insulin signaling cascade in normal and high-fat-fed rodent skeletal muscle J Appl Physiol, May 1, 2004; 96(5): 1691 - 1700. [Abstract] [Full Text] [PDF]

				J. J. Collier and D. K. Scott Sweet Changes: Glucose Homeostasis Can Be Altered by Manipulating Genes Controlling Hepatic Glucose Metabolism Mol. Endocrinol., May 1, 2004; 18(5): 1051 - 1063. [Abstract] [Full Text] [PDF]

				A. NANDI, Y. KITAMURA, C. R. KAHN, and D. ACCILI Mouse Models of Insulin Resistance Physiol Rev, April 1, 2004; 84(2): 623 - 647. [Abstract] [Full Text] [PDF]

				K. Mahadev, H. Motoshima, X. Wu, J. M. Ruddy, R. S. Arnold, G. Cheng, J. D. Lambeth, and B. J. Goldstein The NAD(P)H Oxidase Homolog Nox4 Modulates Insulin-Stimulated Generation of H2O2 and Plays an Integral Role in Insulin Signal Transduction Mol. Cell. Biol., March 1, 2004; 24(5): 1844 - 1854. [Abstract] [Full Text] [PDF]

				A. Suryawan, P. M. J. O'Connor, S. R. Kimball, J. A. Bush, H. V. Nguyen, L. S. Jefferson, and T. A. Davis Amino Acids Do Not Alter the Insulin-Induced Activation of the Insulin Signaling Pathway in Neonatal Pigs J. Nutr., January 1, 2004; 134(1): 24 - 30. [Abstract] [Full Text] [PDF]

				Y. Deng, S. Bhattacharya, O. R. Swamy, R. Tandon, Y. Wang, R. Janda, and H. Riedel Growth Factor Receptor-binding Protein 10 (Grb10) as a Partner of Phosphatidylinositol 3-Kinase in Metabolic Insulin Action J. Biol. Chem., October 10, 2003; 278(41): 39311 - 39322. [Abstract] [Full Text] [PDF]

				V. De Leo, A. la Marca, and F. Petraglia Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome Endocr. Rev., October 1, 2003; 24(5): 633 - 667. [Abstract] [Full Text] [PDF]

				H. Matsuzaki, H. Daitoku, M. Hatta, K. Tanaka, and A. Fukamizu Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation PNAS, September 30, 2003; 100(20): 11285 - 11290. [Abstract] [Full Text] [PDF]

				H. Daitoku, K. Yamagata, H. Matsuzaki, M. Hatta, and A. Fukamizu Regulation of PGC-1 Promoter Activity by Protein Kinase B and the Forkhead Transcription Factor FKHR Diabetes, March 1, 2003; 52(3): 642 - 649. [Abstract] [Full Text] [PDF]

				G. Pandini, F. Frasca, R. Mineo, L. Sciacca, R. Vigneri, and A. Belfiore Insulin/Insulin-like Growth Factor I Hybrid Receptors Have Different Biological Characteristics Depending on the Insulin Receptor Isoform Involved J. Biol. Chem., October 11, 2002; 277(42): 39684 - 39695. [Abstract] [Full Text] [PDF]

				M. Li, J. F. Youngren, A. Dunaif, I. D. Goldfine, B. A. Maddux, B. B. Zhang, and J. L. Evans Decreased Insulin Receptor (IR) Autophosphorylation in Fibroblasts from Patients with PCOS: Effects of Serine Kinase Inhibitors and IR Activators J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4088 - 4093. [Abstract] [Full Text] [PDF]

				G. Jiang, Q. Dallas-Yang, Z. Li, D. Szalkowski, F. Liu, X. Shen, M. Wu, G. Zhou, T. Doebber, J. Berger, et al. Potentiation of Insulin Signaling in Tissues of Zucker Obese Rats After Acute and Long-Term Treatment With PPAR{gamma} Agonists Diabetes, August 1, 2002; 51(8): 2412 - 2419. [Abstract] [Full Text] [PDF]

				B. J. Goldstein Protein-Tyrosine Phosphatases: Emerging Targets for Therapeutic Intervention in Type 2 Diabetes and Related States of Insulin Resistance J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2474 - 2480. [Full Text] [PDF]

				K. Vosseller, L. Wells, M. D. Lane, and G. W. Hart Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes PNAS, April 16, 2002; 99(8): 5313 - 5318. [Abstract] [Full Text] [PDF]

				D. A. Buckley, A. Cheng, P. A. Kiely, M. L. Tremblay, and R. O'Connor Regulation of Insulin-Like Growth Factor Type I (IGF-I) Receptor Kinase Activity by Protein Tyrosine Phosphatase 1B (PTP-1B) and Enhanced IGF-I-Mediated Suppression of Apoptosis and Motility in PTP-1B-Deficient Fibroblasts Mol. Cell. Biol., April 1, 2002; 22(7): 1998 - 2010. [Abstract] [Full Text] [PDF]

				A. R. Gosmanov and D. B. Thomason Insulin and Isoproterenol Differentially Regulate Mitogen-Activated Protein Kinase-Dependent Na+-K+-2Cl- Cotransporter Activity in Skeletal Muscle Diabetes, March 1, 2002; 51(3): 615 - 623. [Abstract] [Full Text] [PDF]